AvidBiotics Corp. and DuPont Nutrition & Health DD today announced a
collaboration aimed at significantly improving food safety. The agreement,
which includes a DuPont Ventures equity investment, gives DuPont worldwide,
exclusive rights to AvidBiotics' antibacterial protein technology in the broad
realm of food and food protection. AvidBiotics retains all rights to
applications of its technology in the fields of animal health, human
therapeutics, human prophylactics and human diagnostics.
“As a global leader in the field of food science and safety, DuPont is an
ideal partner to help us realize the full potential of our Purocin™
antibacterial protein technology for food-related applications,” said James L.
Knighton, President of AvidBiotics, Inc. “This collaboration provides us with
the needed resources to advance our efforts against the most important
food-borne pathogens, the seriousness of which as a health threat is only
compounded by the increasing resistance of many of these organisms to
antibiotics. Along with DuPont, we will continue to advance our most immediate
product opportunity in food protection against E. coli 0157:H7.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in